Medigene AG
MDGEF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16,177 | -$8,330 | -$9,983 | -$28,875 |
| Dep. & Amort. | $1,463 | $21,852 | $3,428 | $6,472 |
| Deferred Tax | $0 | -$46,198 | -$6,528 | -$11,894 |
| Stock-Based Comp. | $307 | $350 | $651 | $662 |
| Change in WC | -$3 | -$885 | -$4,683 | -$2,861 |
| Other Non-Cash | -$709 | $45,187 | $6,361 | $11,710 |
| Operating Cash Flow | -$15,119 | $11,976 | -$10,754 | -$24,786 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$664 | -$1,007 | -$125 | -$484 |
| Net Acquisitions | $0 | $2 | $33 | $24 |
| Inv. Purchases | -$3,048 | -$11,000 | -$4,151 | $0 |
| Inv. Sales/Matur. | $0 | $11,050 | $4,118 | $20,578 |
| Other Inv. Act. | $6,096 | -$11,050 | $4,151 | $1,000 |
| Investing Cash Flow | $2,384 | -$12,005 | $4,026 | $21,118 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$171 | -$171 | -$191 | -$284 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$605 | -$111 | -$842 | -$542 |
| Financing Cash Flow | -$776 | -$282 | -$1,033 | -$826 |
| Forex Effect | -$39 | $118 | $144 | -$155 |
| Net Chg. in Cash | -$13,550 | -$193 | -$7,616 | -$4,649 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,224 | $22,417 | $30,033 | $34,682 |
| End Cash | $8,674 | $22,224 | $22,417 | $30,033 |
| Free Cash Flow | -$15,783 | $10,969 | -$10,879 | -$25,270 |